NAPSA anticorps (AA 20-158)

N° du produit ABIN1845258

Cet anticorps anti-NAPSA Monoclonal Souris (ABIN1845258) détecte spécifiquement NAPSA dans IHC, WB et ELISA. L’anticorps est réactif avec des échantillons de Humain et Rat.

Aperçu rapide pour NAPSA anticorps (AA 20-158) (ABIN1845258)

Antigène: NAPSA (Napsin A Aspartic Peptidase (NAPSA))

Reactivité: Humain, Rat

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp NAPSA est non-conjugé

Application: Immunohistochemistry (IHC), Western Blotting (WB), ELISA

Détail du produit anti-NAPSA anticorps

Épitope: AA 20-158

Purification: Purified antibody

Immunogène: Purified recombinant fragment of human NAPSA (AA: 20-158) expressed in E. coli.

Isotype: IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1.0 mg/mL

Buffer: PBS with 0.05 % sodium azide and 0.5 % protein stabilizer.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.

Détails sur NAPSA

Antigène: NAPSA (Napsin A Aspartic Peptidase (NAPSA))

Autre désignation: NAPSA

Sujet: The activation peptides of aspartic proteinases plays role as inhibitors of the active site.These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens.The pronapsin A gene is expressed predominantly in lung and kidney.Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.

Poids moléculaire: 45.4 kDa

ID gène: 9476

Pathways: Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis